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Over-the-Counter Antifungal
Therapy--A Word of Caution
Major changes in the delivery of health care are occurring in an attempt to control
runaway medical costs. One such change is the diversion of physician-prescribed
therapeutics to over-the-counter (OTC) status, allowing the patient to self-diagnose
and self-treat. The Federal Drug Administration (FDA) has adopted criteria, in
addition to the usual evidence that the agent must be safe and effective, for OTC
drugs to ensure the safety of their use. These criteria include consistency (a
response highly likely to occur each time), simplicity (convenient for self-medica-
tion with one primary pharmacologic effect), and safety (no important interactions
with other drugs, foods, or diseases). These standards and increasing postmarket-
ing surveillance were designed to add important safety measures to prevent or
control side effects associated with OTCs.
Unfortunately, the standards neglect to address the accuracy of a patient’s
self-diagnosis. To what degree can we be guaranteed that patients with complaints
of symptoms and self-detected signs of a lower genital tract infection will correctly
diagnose themselves as having vulvovaginal candidiasis (VVC) as opposed to a
potentially dangerous sexually transmitted disease (STD)? The symptoms of in-
creased vaginal discharge and vulvar pruritus also characterize vaginitis secondary
to Trichomonas vaginalis, a sexually transmitted parasite shown to be associated with
Neisseria gonorrhoeae endocervical infection.
2 I-Iow often have clinicians heard
their patients refer to their chief complaint of an abnormal vaginal discharge as "a
yeast infection"? Would not a patient with an abnormal vaginal discharge due to
mucopurulent endocervicitis secondary to Chlamydia trachomat# infection be falsely
reassured if self-treatment with a vaginal medication temporarily improved her
symptoms?
In the face of a continued epidemic of STDs, we would be more prudent to first
appeal for more reliable diagnostics that could be used in the privacy of one’s home
to suggest the appropriate treatment of uncomplicated local infections. Moreover,
prospective studies evaluating a patient’s ability to accurately self-diagnose are in
order. Most physicians have no concern with the low-risk patient, previously
diagnosed in the office, utilizing an OTC antifungal when typical symptoms of a
recurrent episode ofVVC occur. However, the sexually active adolescent, fearful
of an office visit and denying the possibility of exposure to an STD, may well
utilize the same OTC products incorrectly. Let us ensure that we do not "put the
cart before the horse," especially at a time when new pressure is being placed on the
FDA to allow oral antibiotics to be available OTC.
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